by PEAK Medicals | 4 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Antibody Drug Conjugates AstraZeneca & Daiichi-Sankyo Best Practices in Managing Adverse...
by PEAK Medicals | 4 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Immunotherapies MSD Symposium Insights into the treatment of resectable, non-targetable NSCLC...
by PEAK Medicals | 4 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Targeted Therapies Targeted Therapies Decoding Actionable Alterations: Insights from KRAS,...
by PEAK Medicals | 4 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To Biomarkers Biomarkers Advancements in Lung Cancer Diagnostics: Current Guidelines and...
by PEAK Medicals | 4 October 2024
Indication Area All Sessions Resectable NSCLC Metastatic NSCLC SCLC Biomarker Tests & Diagnostics Targeted Therapies Immunotherapies Antibody-Drug Conjugates Talks Related To SCLC SCLC Reshaping Our Approaches in SCLC: Latest Therapeutic Options and Future Strategies...
